SureTrader
Home > Boards > US OTC > Cannabis > GW Pharmaceuticals , Inc. (GWPRF)

#GWPRF: Ready for the PROMISED LAND ...:-}

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
captainscotty Member Profile
Member Level 
Followed By 248
Posts 9,723
Boards Moderated 16
Alias Born 12/15/12
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 5:49:31 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/14/2018 4:16:54 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 11:37:20 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/14/2018 6:45:15 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 6:38:19 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 6:04:53 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2018 9:54:07 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/5/2018 4:47:26 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/8/2018 4:07:39 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 12/21/2017 11:59:36 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/12/2017 6:04:09 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/8/2017 3:22:53 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/8/2017 6:18:14 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/5/2017 5:31:01 PM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 12/4/2017 7:03:41 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/4/2017 7:02:28 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/3/2017 4:07:12 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/1/2017 4:02:33 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/19/2017 4:06:34 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/11/2017 5:15:09 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/11/2017 4:03:09 PM
MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing InvestorsHub NewsWire - 8/30/2017 10:29:33 PM
PotNetwork Holdings, Inc Confirmed for MJAC 2017 InvestorsHub NewsWire - 8/28/2017 10:43:55 AM
MJAC 2017 International Cannabis Conference - Discount Code InvestorsHub NewsWire - 8/25/2017 6:50:56 PM
captainscotty Member Level  Wednesday, 06/01/16 05:20:13 PM
Re: The Promised Land post# 852
Post # of 863 
#GWPRF: Ready for the PROMISED LAND ...:-}

http://247wallst.com/healthcare-business/2016/05/25/5-major-clinical-trial-results-coming-up/

Pharmaceutical and biotech companies generally must endure the lengthy process that is getting their drug candidates to market through clinical trials. There is a fair amount to a great amount of risk involved, should a study come back negative or should a candidate not be approved. On the other hand, if a drug is approved or passes a clinical trial, there can be massive upside.


Suffice it to say, U.S. Food and Drug Administration (FDA) rulings and positive or negative trial results can make or break these companies.


Read more: Vertex Pharmaceuticals and Others With Major Clinical Trial Results Coming Up (NASDAQ: VRTX) - 24/7 Wall St. http://247wallst.com/healthcare-business/2016/05/25/5-major-clinical-trial-results-coming-up/#ixzz4AMh0uGbb
Follow us: @247wallst on Twitter | 247wallst on Facebook


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist